| Tag | Content |
|---|
EnhancerAtlas ID | HS018-22129 |
Organism | Homo sapiens |
Tissue/cell | CD19+ |
Coordinate | chr7:151622500-151623400 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| MITF | MA0620.2 | chr7:151622583-151622601 | GATGGTCACATGACCTCC | + | 6.57 | | MITF | MA0620.2 | chr7:151622583-151622601 | GATGGTCACATGACCTCC | - | 6.57 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_09822 | chr7:151616722-151625095 | CD14 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH07I151922 | chr7 | 151619761 | 151623870 |
|
Enhancer Sequence | TCTTTAAAGC GCCTCATACA TCCATCAGTG TCTTCTGTAC ATCGTACTTC CTTCATGCTC 60
TGAAATCGAA TTCGTTCAAA TCAGATGGTC ACATGACCTC CTCAATAAAA ATTAACATGG 120
ATTGAGTGTA GCTCTGTTCT AGGTCTGAGC TATCTCATTA ATTGTCACAA CGTCATCTCG 180
TTTGCCCTTC AGATGGCCTG TGGGCTTGTT TTTATTTTCT CCGCTTAGTG CCGGACACCA 240
TCTTGGAGGA CGAGTGTGGG TTTCCTGCGT TAAAGCAGCC GGCCGGGCAG AGCTGAGCAA 300
ACCCCAGGAC TTCCGACTCA GAATCTACAC AGAACACAGC CTCCCTCGGA CTGATGTTTG 360
CTCTGCCCTT CACAGTTTGA AGATAATGAT CCTGGATAGA ATAGAAGCCA AATAAGAGTT 420
CAGCAGCTCT GTGTTTTCAT CTGTTTAATG TCACCATCTG TCCCAAGCGG GGAGCCTCTT 480
CTTTCTTGTT CCTGTTTTTC TGAGCATGAC TAAAATCTAT TTTAAAAGTT GACTCAGCAT 540
GACTTGCAAG CCTTCGTTCA GGATGGTTCT TAGCTTTTGT GACACGGTTT AGCCTCTGCC 600
CCTCTTTTCT GTATGTCCTG GGTTATGATC AGTTTAGCAG CAGGGAAGAA TCTGGGTTTG 660
AAGTTTGGCT GACCTGAATT TGAATTGTGA ATCTTGGCAA TAGACCAGTC AGCAGCTATG 720
TGAACTCAAG TGACTCCATC TTCCTGAGCC TCTGCCTCCT TGAGTGACAA CCACCACCCC 780
TGCCGTGCTC CATGTCCCTG TGCGGCTCCT CCCACTCTGC ATCCGGGCTG GCCCTGTGCC 840
TCGCTTTGCC AACAGAAAGC GCCAGAATGA TGCTGTGCCA CTCCCAGTCT AGGCCACGAG 900
|
